Inhibitors of Rho kinase (ROCK) signaling revert the malignant phenotype of breast cancer cells in 3D context

Oncotarget. 2016 May 31;7(22):31602-22. doi: 10.18632/oncotarget.9395.

Abstract

Loss of polarity and quiescence along with increased cellular invasiveness are associated with breast tumor progression. ROCK plays a central role in actin-cytoskeletal rearrangement. We used physiologically relevant 3D cultures of nonmalignant and cancer cells in gels made of laminin-rich extracellular matrix, to investigate ROCK function. Whereas expression levels of ROCK1 and ROCK2 were elevated in cancer cells compared to nonmalignant cells, this was not observed in 2D cultures. Malignant cells showed increased phosphorylation of MLC, corresponding to disorganized F-actin. Inhibition of ROCK signaling restored polarity, decreased disorganization of F-actin, and led to reduction of proliferation. Inhibition of ROCK also decreased EGFR and Integrinβ1 levels, and consequently suppressed activation of Akt, MAPK and FAK as well as GLUT3 and LDHA levels. Again, ROCK inhibition did not inhibit these molecules in 2D. A triple negative breast cancer cell line, which lacks E-cadherin, had high levels of ROCK but was less sensitive to ROCK inhibitors. Exogenous overexpression of E-cadherin, however, rendered these cells strikingly sensitive to ROCK inhibition. Our results add to the growing literature that demonstrate the importance of context and tissue architecture in determining not only regulation of normal and malignant phenotypes but also drug response.

Keywords: ROCK; breast cancer; invasiveness; polarity; three-dimensional culture.

MeSH terms

  • Actin Cytoskeleton / drug effects
  • Actin Cytoskeleton / enzymology
  • Antigens, CD
  • Antineoplastic Agents / pharmacology*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / enzymology
  • Breast Neoplasms / genetics
  • Breast Neoplasms / pathology
  • Cadherins / genetics
  • Cadherins / metabolism
  • Cancer-Associated Fibroblasts / drug effects
  • Cancer-Associated Fibroblasts / enzymology
  • Cancer-Associated Fibroblasts / pathology
  • Cell Line, Tumor
  • Cell Polarity / drug effects*
  • Cell Proliferation / drug effects
  • Coculture Techniques
  • Dose-Response Relationship, Drug
  • Drug Resistance, Neoplasm
  • Female
  • Humans
  • Molecular Targeted Therapy
  • Phenotype
  • Protein Kinase Inhibitors / pharmacology*
  • Signal Transduction / drug effects*
  • Transfection
  • Triple Negative Breast Neoplasms / drug therapy
  • Triple Negative Breast Neoplasms / enzymology
  • Triple Negative Breast Neoplasms / pathology
  • rho-Associated Kinases / antagonists & inhibitors*
  • rho-Associated Kinases / metabolism
  • rhoA GTP-Binding Protein / metabolism

Substances

  • Antigens, CD
  • Antineoplastic Agents
  • CDH1 protein, human
  • Cadherins
  • Protein Kinase Inhibitors
  • RHOA protein, human
  • ROCK1 protein, human
  • ROCK2 protein, human
  • rho-Associated Kinases
  • rhoA GTP-Binding Protein